This inventor holds 7 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignees: Bayer Aktiengesellschaft, The Broad Institute, Inc., Bayer Pharma Aktiengesellschaft. Active years: 2022-2025.
Company Filing History:
6 out of 12,266 
6 out of 482 
5 out of 386 
Years Active: 2022-2025
Title: Ulrike Rauh: Innovator in Pharmaceutical Chemistry
Introduction
Ulrike Rauh is a prominent inventor based in Leverkusen, Germany. She has made significant contributions to the field of pharmaceutical chemistry, holding a total of seven patents. Her work primarily focuses on developing innovative compounds that serve as potential treatments for various proliferative disorders.
Latest Patents
Among her latest patents is a compound known as 3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one, which acts as a Casein kinase 1 alpha and/or delta (CSNK1α and/or β) inhibitor. This invention relates to the production processes of these compounds and their use as pharmaceuticals. Another notable patent involves macrocyclic fluorine-substituted indole derivatives, which are designed for the treatment or prophylaxis of hyperproliferative disorders. This patent includes methods for preparing these compounds and their pharmaceutical compositions.
Career Highlights
Ulrike has worked with esteemed organizations such as the Broad Institute, Inc. and Bayer Aktiengesellschaft. Her experience in these companies has allowed her to collaborate on groundbreaking research and development projects in the pharmaceutical industry.
Collaborations
Ulrike has collaborated with notable colleagues, including Anne Mengel and Clara Christ. These partnerships have contributed to her success and the advancement of her innovative work.
Conclusion
Ulrike Rauh's contributions to pharmaceutical chemistry through her patents and collaborations highlight her role as a leading inventor in the field. Her work continues to pave the way for new treatments for proliferative disorders.